Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rijken

Showing results (31-40 of 810) with videos related to

Pageof 81
Sort By:
Diabetes Research and Clinical Practice|September 11, 2003
Health care use by diabetic patients in the Netherlands: patterns and predicting factorsF El Fakiri, M Foets, M Rijken
Thrombosis and Haemostasis|February 26, 2004
Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis modelAna H C Guimarães, Dingeman C Rijken
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 5, 2015
Health-related needs of people with multiple chronic diseases: differences and underlying factorsPetra Hopman, François G Schellevis, Mieke Rijken
Biomed Research International|August 2, 2017
Inhibition of Fibrinolysis by Coagulation Factor XIIIDingeman C Rijken, Shirley Uitte de Willige
Thrombosis and Haemostasis|October 1, 1981
Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in cultureK Bykowska, D C Rijken, D Collen
The Journal of Laboratory and Clinical Medicine|April 1, 1981
Immunological characterization of plasminogen activator activities in human tissues and body fluidsD C Rijken, G Wijngaards, J Welbergen
Scandinavian Journal of Primary Health Care|May 12, 2015
Individual care plans for chronically ill patients within primary care in the Netherlands: Dissemination and associations with patient characteristics and patient-perceived quality of careDaphne L Jansen, Monique Heijmans, Mieke Rijken
Seminars in Thrombosis and Hemostasis|June 7, 2015
The Fibrinolytic Status in Liver DiseasesFrank W G Leebeek, Dingeman C Rijken
Political Behavior|September 5, 2022
The Income Gap in Voting: Moderating Effects of Income Inequality and ClientelismTwan Huijsmans, Arieke J Rijken, Teodora Gaidyte
Thrombosis and Haemostasis|June 30, 1981
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitroO Matsuo, D C Rijken, D Collen
Pageof 81

Showing results (31-40 of 810) with videos related to

Sort By:
Pageof 81
Diabetes Research and Clinical Practice|September 11, 2003
Health care use by diabetic patients in the Netherlands: patterns and predicting factorsF El Fakiri, M Foets, M Rijken
Thrombosis and Haemostasis|February 26, 2004
Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis modelAna H C Guimarães, Dingeman C Rijken
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 5, 2015
Health-related needs of people with multiple chronic diseases: differences and underlying factorsPetra Hopman, François G Schellevis, Mieke Rijken
Biomed Research International|August 2, 2017
Inhibition of Fibrinolysis by Coagulation Factor XIIIDingeman C Rijken, Shirley Uitte de Willige
Thrombosis and Haemostasis|October 1, 1981
Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in cultureK Bykowska, D C Rijken, D Collen
The Journal of Laboratory and Clinical Medicine|April 1, 1981
Immunological characterization of plasminogen activator activities in human tissues and body fluidsD C Rijken, G Wijngaards, J Welbergen
Scandinavian Journal of Primary Health Care|May 12, 2015
Individual care plans for chronically ill patients within primary care in the Netherlands: Dissemination and associations with patient characteristics and patient-perceived quality of careDaphne L Jansen, Monique Heijmans, Mieke Rijken
Seminars in Thrombosis and Hemostasis|June 7, 2015
The Fibrinolytic Status in Liver DiseasesFrank W G Leebeek, Dingeman C Rijken
Political Behavior|September 5, 2022
The Income Gap in Voting: Moderating Effects of Income Inequality and ClientelismTwan Huijsmans, Arieke J Rijken, Teodora Gaidyte
Thrombosis and Haemostasis|June 30, 1981
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitroO Matsuo, D C Rijken, D Collen
Pageof 81